Genomics

Dataset Information

Th17 Pathogenicity Natalizumab


ABSTRACT: RNA-sequencing of FACS-sorted MCAM+CCR6+ Th17 cells derived from treatment-naive MS patients and MS patients with long-term Natalizumab treatment

PROVIDER: PRJEB56578 | ENA |

REPOSITORIES: ENA